Trials / Completed
CompletedNCT00069082
Intranasal Civamide for Episodic Cluster Headache
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Winston Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Civamide (Zucapsaicin) | Nasal Solution 0.01% |
| DRUG | Sodium Chloride | Nasal Solution 10% |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2004-01-01
- Completion
- 2004-01-01
- First posted
- 2003-09-16
- Last updated
- 2011-06-10
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00069082. Inclusion in this directory is not an endorsement.